Overview

TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of candesartan cilexetil in preventing hypertension in people with high normal blood pressure. Patients will be randomized to either Candesartan or placebo for an initial 2-year period followed by a second 2-year period of placebo for all patients.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Candesartan
Candesartan cilexetil